Dr. Lal Path Labs Share Price

Dr. Lal PathLabs Limited is an India-based provider of diagnostic and related healthcare tests and services. The Company is engaged primarily in the business of running laboratories for carrying out pathological investigations in various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It offers a range of tests, including Pregnancy Test, Full Body Checkups, Covid 19 Test, Heart Test, Kidney Test, Liver Test, Cholesterol Test, Hepatitis B Test, Kidney Function Test, Sugar Test, Thyroid Test, Typhoid Test, Uric Acid Test, Vitamin B12 Test and vitamin D Test. It has approximately 298 clinical laboratories (including National Reference Lab at Delhi, Regional Reference Lab in Kolkata, Bangalore and Mumbai), 6,607 patient service centers, and 12,365 pick-up points (PUPs). Its customers include individual patients, hospitals, and corporate customers.As of 15 Jun 2026, Dr. Lal Path Labs share price is ₹1,601.20. The stock opened at ₹1,607.60, compared to its previous close of ₹1,593.50. During today's trading session, Dr. Lal Path Labs share price moved in the range of ₹1,585.90 to ₹1,634.00, with an average price of ₹1,609.95 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,585.90 and a high of ₹1,634.00. On the performance front, Dr. Lal Path Labs share price has increased by 11.43% over the last six months and is up 7.79% on a year-on-year basis.

The market capitalization of Dr. Lal Path Labs is ₹26,830 Crs, with a P/E ratio of 52.6 and a dividend yield of 1.53%.